Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy

Aim: to review the common risk factors and links in the pathogenesis of functional gastrointestinal disorders (FGID) to optimize therapy of patients with a combination of multiple FGID.Key points. FGID occurs in more than 40 % of people globally, mainly affecting the working-age population in young...

Full description

Bibliographic Details
Main Authors: S. N. Mekhdiyev, O. A. Mekhdieva, O. M. Berko
Format: Article
Language:Russian
Published: Gastro LLC 2022-12-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/755
_version_ 1797245173469544448
author S. N. Mekhdiyev
O. A. Mekhdieva
O. M. Berko
author_facet S. N. Mekhdiyev
O. A. Mekhdieva
O. M. Berko
author_sort S. N. Mekhdiyev
collection DOAJ
description Aim: to review the common risk factors and links in the pathogenesis of functional gastrointestinal disorders (FGID) to optimize therapy of patients with a combination of multiple FGID.Key points. FGID occurs in more than 40 % of people globally, mainly affecting the working-age population in young and middle-aged subjects. At the same time, more than 30 % of patients have a combination of 2 or more functional gastrointestinal (GI) disorders i.e. overlap syndrome. Common links in the pathogenesis of FGID include disorders of gut-brain interaction, visceral hypersensitivity, changes in intestinal microbiota, overproduction of proinflammatory cytokines, impaired epithelial permeability and motor activity of the gastrointestinal tract. The combination of FGID in various gastrointestinal segments is associated with more pronounced clinical symptoms (mutual burden syndrome). Common risk factors and pathogenetic links of the functional disorders enables reducing the number of prescribed medications when several FGIDs overlap in one patient, which also increases adherence to therapy. Treatment of FGID includes adjustment of risk factors and drug therapy. As a pathogenetically justified pharmacotherapy of overlap syndrome, Kolofort, highly diluted antibodies to TNF-α, histamine and brain-specific protein S-100, is of interest.Conclusion. Kolofort has demonstrated high efficacy and safety including among patients with overlap FGID enabling to consider it as the treatment of choice in these patients.
first_indexed 2024-03-08T09:20:43Z
format Article
id doaj.art-21eb1ff8fa85442b86350b2f6916cc00
institution Directory Open Access Journal
issn 1382-4376
2658-6673
language Russian
last_indexed 2024-04-24T19:22:42Z
publishDate 2022-12-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj.art-21eb1ff8fa85442b86350b2f6916cc002024-03-25T16:53:10ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732022-12-013249510310.22416/1382-4376-2022-32-4-95-103496Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational TherapyS. N. Mekhdiyev0O. A. Mekhdieva1O. M. Berko2First St. Petersburg State Medical University named after Academician I.P. Pavlov; Gastroenterological Center “Expert” LLCFirst St. Petersburg State Medical University named after Academician I.P. Pavlov; Gastroenterological Center “Expert” LLCGastroenterological Center “Expert” LLCAim: to review the common risk factors and links in the pathogenesis of functional gastrointestinal disorders (FGID) to optimize therapy of patients with a combination of multiple FGID.Key points. FGID occurs in more than 40 % of people globally, mainly affecting the working-age population in young and middle-aged subjects. At the same time, more than 30 % of patients have a combination of 2 or more functional gastrointestinal (GI) disorders i.e. overlap syndrome. Common links in the pathogenesis of FGID include disorders of gut-brain interaction, visceral hypersensitivity, changes in intestinal microbiota, overproduction of proinflammatory cytokines, impaired epithelial permeability and motor activity of the gastrointestinal tract. The combination of FGID in various gastrointestinal segments is associated with more pronounced clinical symptoms (mutual burden syndrome). Common risk factors and pathogenetic links of the functional disorders enables reducing the number of prescribed medications when several FGIDs overlap in one patient, which also increases adherence to therapy. Treatment of FGID includes adjustment of risk factors and drug therapy. As a pathogenetically justified pharmacotherapy of overlap syndrome, Kolofort, highly diluted antibodies to TNF-α, histamine and brain-specific protein S-100, is of interest.Conclusion. Kolofort has demonstrated high efficacy and safety including among patients with overlap FGID enabling to consider it as the treatment of choice in these patients.https://www.gastro-j.ru/jour/article/view/755functional dyspepsiaibsabdominal painoverlap syndrome
spellingShingle S. N. Mekhdiyev
O. A. Mekhdieva
O. M. Berko
Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
functional dyspepsia
ibs
abdominal pain
overlap syndrome
title Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
title_full Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
title_fullStr Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
title_full_unstemmed Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
title_short Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
title_sort overlap of functional gastrointestinal disorders common mechanisms of pathogenesis as a key to rational therapy
topic functional dyspepsia
ibs
abdominal pain
overlap syndrome
url https://www.gastro-j.ru/jour/article/view/755
work_keys_str_mv AT snmekhdiyev overlapoffunctionalgastrointestinaldisorderscommonmechanismsofpathogenesisasakeytorationaltherapy
AT oamekhdieva overlapoffunctionalgastrointestinaldisorderscommonmechanismsofpathogenesisasakeytorationaltherapy
AT omberko overlapoffunctionalgastrointestinaldisorderscommonmechanismsofpathogenesisasakeytorationaltherapy